According to documents submitted to the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company MapLight Therapeutics, Inc. announced that its Chief Financial Officer Vishwas Setia has resigned with immediate effect as of June 18, 2026.

According to documents submitted to the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company MapLight Therapeutics, Inc. announced that its Chief Financial Officer Vishwas Setia has resigned with immediate effect as of June 18, 2026.

老虎证券2026/06/18 21:17

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

The document shows that Setia's resignation will take effect immediately from June 18, 2026. Currently, the company has not announced a succession plan for the Chief Financial Officer position. This personnel change was disclosed through an official SEC filing, marking a significant adjustment in the company's management team.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to documents submitted to the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company MapLight Therapeutics, Inc. announced that its Chief Financial Officer Vishwas Setia has resigned with immediate effect as of June 18, 2026.

You may also like

Crypto prices